Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 35% ± 14% | |
peripheral blood | 15 studies | 31% ± 7% | |
intestine | 10 studies | 34% ± 15% | |
kidney | 7 studies | 31% ± 6% | |
brain | 7 studies | 26% ± 6% | |
eye | 5 studies | 30% ± 14% | |
bone marrow | 5 studies | 23% ± 7% | |
lymph node | 5 studies | 30% ± 10% | |
liver | 5 studies | 33% ± 15% | |
pancreas | 4 studies | 66% ± 11% | |
placenta | 4 studies | 49% ± 16% | |
uterus | 4 studies | 44% ± 20% | |
prostate | 4 studies | 36% ± 17% | |
breast | 4 studies | 36% ± 6% | |
skin | 3 studies | 36% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8146.00 | 1445 / 1445 | 100% | 198.72 | 183 / 183 |
lung | 100% | 8512.52 | 578 / 578 | 100% | 300.19 | 1155 / 1155 |
ovary | 100% | 8243.41 | 180 / 180 | 100% | 238.31 | 430 / 430 |
pancreas | 100% | 12211.71 | 328 / 328 | 100% | 210.39 | 178 / 178 |
prostate | 100% | 7981.75 | 245 / 245 | 100% | 377.04 | 502 / 502 |
breast | 100% | 8544.51 | 459 / 459 | 100% | 364.42 | 1117 / 1118 |
liver | 100% | 11832.34 | 226 / 226 | 100% | 208.17 | 405 / 406 |
uterus | 100% | 8260.22 | 170 / 170 | 100% | 225.23 | 457 / 459 |
bladder | 100% | 7802.57 | 21 / 21 | 99% | 261.87 | 501 / 504 |
thymus | 100% | 8938.16 | 653 / 653 | 99% | 229.01 | 600 / 605 |
intestine | 100% | 8062.03 | 966 / 966 | 99% | 268.57 | 520 / 527 |
stomach | 100% | 7819.25 | 359 / 359 | 99% | 243.47 | 282 / 286 |
kidney | 100% | 5610.56 | 89 / 89 | 98% | 189.53 | 887 / 901 |
skin | 100% | 10856.32 | 1809 / 1809 | 97% | 187.34 | 460 / 472 |
brain | 97% | 3475.19 | 2573 / 2642 | 100% | 129.54 | 704 / 705 |
adrenal gland | 100% | 8661.69 | 258 / 258 | 97% | 161.70 | 222 / 230 |
blood vessel | 100% | 9001.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 112.53 | 29 / 29 |
spleen | 100% | 5594.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 178.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 175.21 | 1 / 1 |
adipose | 100% | 8528.08 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 5363.48 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 5460.39 | 842 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 110.85 | 75 / 80 |
peripheral blood | 88% | 4786.59 | 814 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001893 | Biological process | maternal placenta development |
GO_0035459 | Biological process | vesicle cargo loading |
GO_0060717 | Biological process | chorion development |
GO_0034260 | Biological process | negative regulation of GTPase activity |
GO_0006954 | Biological process | inflammatory response |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_2000638 | Biological process | regulation of SREBP signaling pathway |
GO_0001947 | Biological process | heart looping |
GO_0090158 | Biological process | endoplasmic reticulum membrane organization |
GO_0032525 | Biological process | somite rostral/caudal axis specification |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0035264 | Biological process | multicellular organism growth |
GO_0006886 | Biological process | intracellular protein transport |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0036499 | Biological process | PERK-mediated unfolded protein response |
GO_0007030 | Biological process | Golgi organization |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0001843 | Biological process | neural tube closure |
GO_0060670 | Biological process | branching involved in labyrinthine layer morphogenesis |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
GO_1903912 | Biological process | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation |
GO_1905069 | Biological process | allantois development |
GO_0048205 | Biological process | COPI coating of Golgi vesicle |
GO_0072595 | Biological process | maintenance of protein localization in organelle |
GO_0048208 | Biological process | COPII vesicle coating |
GO_0009306 | Biological process | protein secretion |
GO_0030137 | Cellular component | COPI-coated vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0042589 | Cellular component | zymogen granule membrane |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
GO_0030133 | Cellular component | transport vesicle |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_0030663 | Cellular component | COPI-coated vesicle membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005119 | Molecular function | smoothened binding |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0005109 | Molecular function | frizzled binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TMED2 |
Protein name | Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1) RNP24 protein (Transmembrane emp24 domain trafficking protein 2, isoform CRA_a) (cDNA, FLJ93436, Homo sapiens coated vesicle membrane protein (RNP24), mRNA) Transmembrane p24 trafficking protein 2 |
Synonyms | hCG_1743563 RNP24 |
Description | FUNCTION: Involved in vesicular protein trafficking. Mainly functions in the early secretory pathway but also in post-Golgi membranes. Thought to act as cargo receptor at the lumenal side for incorporation of secretory cargo molecules into transport vesicles and to be involved in vesicle coat formation at the cytoplasmic side. In COPII vesicle-mediated anterograde transport involved in the transport of GPI-anchored proteins and proposed to act together with TMED10 as their cargo receptor; the function specifically implies SEC24C and SEC24D of the COPII vesicle coat and lipid raft-like microdomains of the ER. Recognizes GPI anchors structural remodeled in the ER by PGAP1 and MPPE1. In COPI vesicle-mediated retrograde transport inhibits the GTPase-activating activity of ARFGAP1 towards ARF1 thus preventing immature uncoating and allowing cargo selection to take place. Involved in trafficking of G protein-coupled receptors (GPCRs). Regulates F2RL1, OPRM1 and P2RY4 exocytic trafficking from the Golgi to the plasma membrane thus contributing to receptor resensitization. Facilitates CASR maturation and stabilization in the early secretory pathway and increases CASR plasma membrane targeting. Proposed to be involved in organization of intracellular membranes such as the maintenance of the Golgi apparatus. May also play a role in the biosynthesis of secreted cargo such as eventual processing. . |
Accessions | ENST00000509052.2 F5GX39 Q15363 ENST00000262225.8 Q6FHT8 E7EQ72 ENST00000438031.2 |